72033-44-4Relevant academic research and scientific papers
Synthesis of the Indole Nucleoside Antibiotics Neosidomycin and SF-2140: Structural Revision of Neosidomycin
Buchanan, J. Grant,Stoddart, Jane,Wightman, Richard H.
, p. 823 - 824 (1989)
Two structurally related indole nucleoside antibiotics, neosidomycin (5) and SF-2140 (3) have been synthesised; it is confirmed that the structure initially proposed for neosidomycin must be revised.
Enantioselective de novo synthesis of 4-deoxy-d-hexopyranoses via hetero-Diels-Alder cycloadditions: Total synthesis of ezoaminuroic acid and neosidomycin
Giguere, Denis,Martel, Julien,Shiao, Tze Chieh,Roy, Rene
, p. 9687 - 9698 (2012/01/03)
The de novo synthesis of carbohydrates constitutes an important aspect of organic chemistry, and its application toward deoxy sugars is particularly noteworthy in targeting biologically active compounds. The enantioselective preparation of 4-deoxy-d-ribo-, 4-deoxy-d-lyxo-, and 4-deoxy-d-xylo- hexopyranosides, along with their uronate counterparts has been successfully accomplished using hetero-Diels - Alder reactions as the key step. Jacobsen chromium(III) catalyst and a titanium - binaphthol complex have been used to successfully catalyze diene and aldehyde cycloadditions, leading to optically active dihydropyran templates. 6-Hydroxydesosamine, orthogonally protected ezoaminuroic acid, and neosidomycin were synthesized using a comparative study. Also, a novel chiron approach to 4-deoxy-lyxo-hexopyranosiduronic acid methyl ester derivatives was efficiently accomplished starting from readily accessible starting materials. This work represents a systematic and comprehensive study toward a de novo synthesis of 4-deoxy-hexopyranoses via enantioselective hetero-Diels-Alder reactions.
Synthesis of the Indole Nucleoside Antibiotics Neosidomycin and SF-2140
Buchanan, J. Grant,Stoddart, Jane,Wightman, Richard H.
, p. 1417 - 1426 (2007/10/02)
The indole nucleoside antibiotics neosidomycin 5 and SF-2140 3 have been synthesized.Methyl 4-deoxy-2,3-O-isopropylidene-α-D-lyxo-hexopyranoside 8 was converted into methyl 1-chloro-1,4-dideoxy-2,3-di-O-pivaloyl-α-D-lyxo-hexopyranuronate 33 in five steps.Silver(I)-catalysed coupling of compound 33 with 3-(cyanomethyl)indole 20 gave stereoselectively an α-nucleoside which was converted into methyl 1--1,4-dideoxy-α-D-lyxo-hexopyranuronate (neosidomycin, 5).Coupling of compound 33 to 3-cyanomethyl-4-methoxyindole 23 by the sodium salt procedure, and subsequent deacylation, gave methyl 1-(3-cyanomethyl-4-methoxyindol-1-yl)-1,4-dideoxy-α-D-lyxo-hexopyranuronate (SF-2140, 3).Neosidomycin, SF-2140, and their O-acyl derivatives adopt a conformation which differs from that of 1-(6-O-benzoyl-4-deoxy-2,3-O-pivaloyl-α-D-lyxo-hexopyranosyl)-3-(cyanomethyl)indole 29, in which the methyl uronate grouping of the antibiotics is present at a lower oxidation level.
